CAGR Value :
The global Platinum based Cancer Drug market was valued at USD 1.44 billion in 2025 and is projected to reach USD 1.76 billion by 2032, exhibiting a CAGR of 2.9% during the forecast period.
Report Studies :
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
By Types :
Cisplatin
Oxaliplatin
Carboplatin
•
Others
By Applications :
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Key Industry Players
• Sanofi
• Jiangsu Hengrui Medicine Co., Ltd.
• ASK Pharma
• Yi Bai Pharmaceutical
• Qilu Pharmaceutical
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Dr. Reddy's Laboratories Ltd.
• Mylan N.V. (Viatris)
• Sun Pharmaceutical Industries Ltd.
• Novartis AG
• Debiopharm Group
• Accord Healthcare Ltd.
• SK Chemicals